Polyethylene Glycol 3350, Sodium Chloride, Sodium Bicarbonate, Potassium Chloride and Bisacodyl Delayed-release Tablet
Polyethylene Glycol 3350, Sodium Chloride, Sodium Bicarbonate, Potassium Chloride and Bisacodyl Delayed-release Tablet is listed in the FDA National Drug Code directory with 1 NDC code, marketed under brand name including GaviLyte-H and Bisacodyl. Available dosage form: kit.
Drug details
- Generic Name
- Polyethylene Glycol 3350, Sodium Chloride, Sodium Bicarbonate, Potassium Chloride and Bisacodyl Delayed-release Tablet
- Brand Names
- GaviLyte-H and Bisacodyl
- Application Number
- ANDA202217
- Sponsor
- Lupin Pharmaceuticals, Inc.
- NDC Codes
- 1
- Dosage Forms
- KIT
- Routes
- ORAL
Indications and Usage
1 INDICATIONS & USAGE GaviLyte - H and bisacodyl delayed-release tablet, USP is indicated for cleansing of the colon as a preparation for colonoscopy in adults. GaviLyte - H and bisacodyl delayed-release tablet, USP is a combination of PEG-3350, an osmotic laxative and bisacodyl, a stimulant laxative, indicated for cleansing of the colon as a preparation for colonoscopy in adults ( 1 )